trending Market Intelligence /marketintelligence/en/news-insights/trending/y0RrYAM76-vHWt3fbCqogw2 content esgSubNav
In This List

CTI BioPharma adds Syndax COO to board

Blog

Insight Weekly: US stock market downturn; Chinese bank earnings; Europe's big tech bills

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022


CTI BioPharma adds Syndax COO to board

CTI BioPharma Corp. appointed Michael Metzger as a board member.

Metzger is currently president and COO of Syndax Pharmaceuticals Inc.